Literature DB >> 25005075

A green four-component synthesis of zwitterionic alkyl/benzyl pyrazolyl barbiturates and their photophysical studies.

Manisha Bihani1, Pranjal P Bora, Ghanashyam Bez, Hassan Askari.   

Abstract

A novel series of unsymmetrically substituted alkyl/benzyl pyrazolyl barbiturates incorporating highly biologically active pyrazolone and barbiturate moieties was synthesized by four-component reactions of a mixture of ethyl acetoacetate, hydrazine hydrate, aldehydes and barbituric acid/thiobarbituric acid in ethanol without using a catalyst. The photophysical properties of the newly designed alkyl/benzyl pyrazolyl barbiturates were studied, and good quantum yield of some products indicated a definitive scope in the field of biochemical applications. Single-crystal X-ray crystallographic studies revealed that the newly synthesized compounds exist in zwitterionic form. The zwitterionic nature of the new chimera makes them interesting candidates for drug delivery as zwitterionic drugs are known to have highly water soluble properties, specific protein absorption, slow recognition by immune system, slow blood clearance from body and can constantly diffuse and deposit throughout the physiological pH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005075     DOI: 10.1007/s11030-014-9532-8

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  24 in total

1.  Lipophilicity Profiles of Ampholytes.

Authors:  Alessandra Pagliara; Pierre-Alain Carrupt; Giulia Caron; Patrick Gaillard; Bernard Testa
Journal:  Chem Rev       Date:  1997-12-18       Impact factor: 60.622

2.  Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks.

Authors:  Zhiqiang Cao; Qiuming Yu; Hong Xue; Gang Cheng; Shaoyi Jiang
Journal:  Angew Chem Int Ed Engl       Date:  2010-05-17       Impact factor: 15.336

3.  Barbituric acid derivative BAS 02104951 inhibits PKCε, PKCη, PKCε/RACK2 interaction, Elk-1 phosphorylation in HeLa and PKCε and η translocation in PC3 cells following TPA-induction.

Authors:  Peter Gruber; Florian Rechfeld; Johannes Kirchmair; Nina Hauser; Markus Boehler; Dorota Garczarczyk; Thierry Langer; Johann Hofmann
Journal:  J Biochem       Date:  2010-12-24       Impact factor: 3.387

4.  Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group.

Authors:  Rabindranath Tripathy; Robert J McHugh; Arup K Ghose; Gregory R Ott; Thelma S Angeles; Mark S Albom; Zeck Huang; Lisa D Aimone; Mangeng Cheng; Bruce D Dorsey
Journal:  Bioorg Med Chem Lett       Date:  2011-10-20       Impact factor: 2.823

5.  Adsorption of zwitterionic drugs onto oxidized cellulose.

Authors:  Dmitry S Zimnitsky; Tatiana L Yurkshtovich; Pavel M Bychkovsky
Journal:  J Colloid Interface Sci       Date:  2005-09-01       Impact factor: 8.128

6.  Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties.

Authors:  Dharmarajan Sriram; Tanushree Ratan Bal; Perumal Yogeeswari
Journal:  J Pharm Pharm Sci       Date:  2005-10-20       Impact factor: 2.327

Review 7.  2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes.

Authors:  Jacques Poupaert; Pascal Carato; Evelina Colacino; Saïd Yous
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

8.  Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.

Authors:  M Liu; D Cao; R Russell; R E Handschumacher; G Pizzorno
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

9.  Pyrazolone based TGFbetaR1 kinase inhibitors.

Authors:  Kevin Guckian; Mary Beth Carter; Edward Yin-Shiang Lin; Michael Choi; Lihong Sun; P Ann Boriack-Sjodin; Claudio Chuaqui; Benjamin Lane; Kam Cheung; Leona Ling; Wen-Cherng Lee
Journal:  Bioorg Med Chem Lett       Date:  2009-10-29       Impact factor: 2.823

10.  Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles.

Authors:  Rochelle R Arvizo; Oscar R Miranda; Daniel F Moyano; Chad A Walden; Karuna Giri; Resham Bhattacharya; J David Robertson; Vincent M Rotello; Joel M Reid; Priyabrata Mukherjee
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.